325 related articles for article (PubMed ID: 30017965)
1. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
[TBL] [Abstract][Full Text] [Related]
2. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
3. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
Qadir XV; Han C; Lu D; Zhang J; Wu T
Am J Pathol; 2014 Aug; 184(8):2355-64. PubMed ID: 24911372
[TBL] [Abstract][Full Text] [Related]
4. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
Ko E; Seo HW; Jung ES; Kim BH; Jung G
Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional and post-transcriptional control of DNA methyltransferase 3B is regulated by phosphatidylinositol 3 kinase/Akt pathway in human hepatocellular carcinoma cell lines.
Mei C; Sun L; Liu Y; Yang Y; Cai X; Liu M; Yao W; Wang C; Li X; Wang L; Li Z; Shi Y; Qiu S; Fan J; Zha X
J Cell Biochem; 2010 Sep; 111(1):158-67. PubMed ID: 20506537
[TBL] [Abstract][Full Text] [Related]
6. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
7. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.
Zheng J; Wu C; Lin Z; Guo Y; Shi L; Dong P; Lu Z; Gao S; Liao Y; Chen B; Yu F
FEBS J; 2014 Jan; 281(1):88-103. PubMed ID: 24138392
[TBL] [Abstract][Full Text] [Related]
8. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
9. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.
Fan H; Chen L; Zhang F; Quan Y; Su X; Qiu X; Zhao Z; Kong KL; Dong S; Song Y; Chan TH; Guan XY
Oncogene; 2012 May; 31(18):2298-308. PubMed ID: 21909138
[TBL] [Abstract][Full Text] [Related]
10. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN.
Tian QH; Zhang MF; Zeng JS; Luo RG; Wen Y; Chen J; Gan LG; Xiong JP
J Mol Med (Berl); 2019 Nov; 97(11):1535-1545. PubMed ID: 31463732
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
12. Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene.
Peng H; Chen Y; Gong P; Cai L; Lyu X; Jiang Q; Wang J; Lu J; Yao K; Liu K; Li J; Li X
Oncotarget; 2016 Jun; 7(26):40025-40037. PubMed ID: 27223069
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
16. Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell.
Zhao Z; Wu Q; Cheng J; Qiu X; Zhang J; Fan H
J Biomed Biotechnol; 2010; 2010():737535. PubMed ID: 20467490
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.
Zhang H; Weng X; Ye J; He L; Zhou D; Liu Y
Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):600-9. PubMed ID: 25683523
[TBL] [Abstract][Full Text] [Related]
18. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
20. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
